{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:30:45Z","timestamp":1792859445870,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Peripheral artery disease in diabetes mellitus represents a distinct clinical entity characterized by diffuse distal arterial disease, medial calcification, microvascular dysfunction, neuropathy, and a pro-thromboinflammatory milieu. These features contribute to atypical presentations, diagnostic challenges, accelerated progression, and elevated risks of limb loss and cardiovascular events. Management requires integrated strategies encompassing metabolic optimization, lifestyle modification, pharmacotherapy, antithrombotic therapy, supervised exercise, and timely revascularization. Emerging approaches, including GLP-1 receptor agonists, SGLT2 inhibitors, and regenerative therapies, show promise in improving vascular, functional, and limb outcomes. Advancing outcomes in diabetic peripheral artery disease will depend on mechanism-driven screening, individualized therapies, and novel interventions to prevent complications.<\/jats:p>","DOI":"10.3389\/fendo.2026.1811582","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:06Z","timestamp":1776658446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral artery disease in diabetes"],"prefix":"10.3389","volume":"17","author":[{"given":"Sheena","family":"Amin","sequence":"first","affiliation":[{"name":"Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Fukaya","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Athavale","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00355-8","article-title":"Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"11","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.827","article-title":"Diabetes and peripheral artery disease: a review","volume":"12","author":"Soyoye","year":"2021","journal-title":"World J Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01606-6","article-title":"Epidemiology and burden of peripheral artery disease in people with type 2 diabetes: a systematic literature review","volume":"15","author":"Verma","year":"2024","journal-title":"Diabetes Ther Res Treat Educ Diabetes Relat Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45080420","article-title":"Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications","volume":"45","author":"Caturano","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000155325.41507.e0","article-title":"Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance","volume":"25","author":"Rask-Madsen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1213177","article-title":"Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis","volume":"10","author":"Cervantes","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040672","article-title":"Microvascular disease, peripheral artery disease, and amputation","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: molecular mechanisms","volume":"1","author":"Aronson","year":"2002","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2064","article-title":"Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions","volume":"32","author":"Angiolillo","year":"2009","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1253\/circj.cj-09-0982","article-title":"Basic principles of platelet biology and clinical implications","volume":"74","author":"Angiolillo","year":"2010","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.109.913376","article-title":"Diabetes and antiplatelet therapy in acute coronary syndrome","volume":"123","author":"Ferreiro","year":"2011","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dbi17-0044","article-title":"Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences","volume":"67","author":"Stehouwer","year":"2018","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-0993-z","article-title":"Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes","volume":"19","author":"Witkowski","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s1056-8727(00)00132-x","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J Diabetes Complicat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01824.x","article-title":"Diabetes mellitus as a prothrombotic condition","volume":"262","author":"Grant","year":"2007","journal-title":"J Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15348","DOI":"10.1038\/s41598-024-65188-w","article-title":"An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus","volume":"14","author":"Zaib","year":"2024","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.320195","article-title":"Peripheral artery disease: molecular mechanisms and novel therapies","volume":"44","author":"Athavale","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2024.04.022","article-title":"The role of genetics in managing peripheral arterial disease","volume":"108","author":"Biagetti","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1093355","article-title":"Medial artery calcification in peripheral artery disease","volume":"10","author":"Kim","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666140212210451","article-title":"Mechanisms of medial arterial calcification in diabetes","volume":"20","author":"Chistiakov","year":"2014","journal-title":"Curr Pharm Des"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.12.008","article-title":"Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization","volume":"19","author":"Schurgers","year":"2013","journal-title":"Trends Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/1526602820931488","article-title":"Balloon angioplasty of infrapopliteal arteries: a systematic review and proposed algorithm for optimal endovascular therapy","volume":"27","author":"Giannopoulos","year":"2020","journal-title":"J Endovasc Ther Off J Int Soc Endovasc Spec"},{"key":"B28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1004","article-title":"Microvascular dysfunction in diabetic foot disease and ulceration","volume":"25","author":"Chao","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvssci.2023.100133","article-title":"Systematic review and meta-analysis of the genetics of peripheral arterial disease","volume":"5","author":"Ochoa Chaar","year":"2024","journal-title":"JVS-Vasc Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran Program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12916-022-02476-0","article-title":"Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians","volume":"20","author":"Xiu","year":"2022","journal-title":"BMC Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.06.004","article-title":"The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes","volume":"57","author":"Ramasamy","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13098-024-01291-2","article-title":"Toe brachial index and not ankle brachial index is appropriate in initial evaluation of peripheral arterial disease in type 2 diabetes","volume":"16","author":"Singhania","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics9080465","article-title":"Current applications and future perspectives of artificial and biomimetic intelligence in vascular surgery and peripheral artery disease","volume":"9","author":"Martelli","year":"2024","journal-title":"Biomimetics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13527","article-title":"Pedal medial arterial calcification in diabetic foot ulcers: a significant risk factor of amputation and mortality","volume":"16","author":"Chen","year":"2024","journal-title":"J Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e160","article-title":"Medial arterial calcification and the risk of amputation of diabetic foot ulcer in patients with diabetic kidney disease","volume":"38","author":"So","year":"2023","journal-title":"J Korean Med Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000470","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212754","article-title":"Transcatheter arterialization of deep veins in chronic limb-threatening ischemia","volume":"388","author":"Shishehbor","year":"2023","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet Lond Engl"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1545","article-title":"Liraglutide for lower limb perfusion in people with type 2 diabetes and peripheral artery disease: the STARDUST randomized clinical trial","volume":"7","author":"Caruso","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMc1712572","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60698-X","article-title":"Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial","volume":"373","author":"Rajamani","year":"2009","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.05.028","article-title":"Effect of pemafibrate on diabetic foot ulceration and gangrene: an exploratory analysis from PROMINENT","volume":"84","author":"Marinho","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.10.009","article-title":"Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events","volume":"82","author":"Thomas","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2025.110929","article-title":"Lp(a): A clinical review","volume":"137","author":"Anchouche","year":"2025","journal-title":"Clin Biochem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13287-019-1254-5","article-title":"Autologous stem cell therapy for peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Gao","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.200","article-title":"Vascular calcification: Molecular mechanisms and therapeutic interventions","volume":"4","author":"Pan","year":"2023","journal-title":"MedComm"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016696","article-title":"Novel receptor for advanced glycation end products-blocking antibody to treat diabetic peripheral artery disease","volume":"10","author":"Johnson","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19859072","article-title":"A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease","volume":"24","author":"Russell","year":"2019","journal-title":"Vasc Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jvssci.2022.05.039","article-title":"Interleukin-6 levels and cardiovascular events in the cardiovascular inflammation reduction trial: consistent associations for incident coronary, cerebrovascular, and peripheral artery disease","volume":"3","author":"Marinho","year":"2022","journal-title":"JVS-Vasc Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jamacardio.2025.4491","article-title":"Rationale, design, and baseline clinical characteristics of the ziltivekimab cardiovascular outcomes trial: interleukin-6 inhibition and atherosclerotic event rate reduction","volume":"11","author":"Ridker","year":"2026","journal-title":"JAMA Cardiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1811582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:07Z","timestamp":1776658447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1811582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":60,"alternative-id":["10.3389\/fendo.2026.1811582"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1811582","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1811582"}}